Advanced Search

Rare Neurological Disorders Stocks List

Symbol Grade Name % Change
OVID C Ovid Therapeutics Inc. -1.24
HRMY F Harmony Biosciences Holdings, Inc. -1.88
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Neurological Disorders Urological Disorders Anticonvulsants Biopharmaceutical Chloroarenes Disorders Epilepsy Ethers Fragile X Syndrome Genodermatoses Narcolepsy Organ Systems Pharmaceutical Piperidines Sedatives Stage Pharmaceutical Stimulants Symptoms Syndromes Takeda Pharmaceutical Company

Related ETFs - A few ETFs which own one or more of the above listed Rare Neurological Disorders stocks.

Symbol Grade Name Weight
BBP D BioShares Biotechnology Products Fund 1.76
BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.82
FDM A First Trust DJ Select MicroCap ETF 0.2
VTWG C Vanguard Russell 2000 Growth ETF 0.03
IWC B iShares Microcap ETF 0.03
View all Rare Neurological Disorders related ETFs...
Compare ETFs
  • Compare BBC to FDM
  • Compare BBP to VTWG
  • Compare FDM to VTWG

    • Recent Signals

    Date Stock Signal Type
    2021-03-05 HRMY Lower Bollinger Band Walk Weakness
    2021-03-05 OVID Calm After Storm Range Contraction

    Recent News for Rare Neurological Disorders Stocks

    Date Stock Title
    Mar 4 HRMY Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results
    Mar 3 OVID FUBO, RKT, TRXC and SOS among midday movers
    Mar 3 OVID Ovid downgraded to sector perform at RBC as shares surge 34% on Takeda deal
    Mar 3 OVID Ovid Shares Rally On Soticlestat Development Pact With Takeda In Rare Epilepsy Syndromes
    Mar 3 OVID The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
    Mar 3 OVID 5 Top Stock Gainers for Wednesday: Michaels, Alcoa, Ovid Therapeutics
    Mar 3 OVID Ovid shares surge 92% after soticlestat deal with Takeda
    Mar 3 OVID Takeda buys epilepsy treatment rights from Ovid for up to $856 mln
    Mar 3 OVID Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
    Mar 2 HRMY Harmony Biosciences Certified As A Great Place To Work For The Third Year In A Row
    Related Industries: Biotechnology
    Related Stock Lists: Neurological Disorders Urological Disorders Anticonvulsants Biopharmaceutical Chloroarenes Disorders Epilepsy Ethers Fragile X Syndrome Genodermatoses Narcolepsy Organ Systems Pharmaceutical Piperidines Sedatives Stage Pharmaceutical Stimulants Symptoms Syndromes Takeda Pharmaceutical Company

    Browse All Tags